Selected research
Industry Research
Blood Compatible Polymers Industry Research Report 2026
Market perspective
The global Blood Compatible Polymers market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Blood Compatible Polymers is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Blood Compatible Polymers is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Blood Compatible Polymers is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Blood Compatible Polymers include Sanofi S.A., Jiangsu Senolo Medical Technology, Baxter International Inc, TOPAS Advanced Polymers GmbH, Evonik Industries AG, Eastman Chemical Company, DowDuPont, Biomaterial USA LLC. and ASM International, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Blood Compatible Polymers market in terms of revenue (US$ million) and, where applicable, sales volume (tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Blood Compatible Polymers Market by Company
Sanofi S.A.
Jiangsu Senolo Medical Technology
Baxter International Inc
TOPAS Advanced Polymers GmbH
Evonik Industries AG
Eastman Chemical Company
DowDuPont
Biomaterial USA LLC.
ASM International
AdvanSource Biomaterials Corporation
Blood Compatible Polymers Segment by Type
Polyethylene
Polytetrafluoroethylene
Polyetheretherketone
Polyethersulfone
Polyvinylchloride
Polysulfone
Poly Propalene
Blood Compatible Polymers Segment by Application
Biomedical and Blood Contacting Devices
Dental
Drug delivery
Blood Compatible Polymers Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blood Compatible Polymers market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Blood Compatible Polymers and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blood Compatible Polymers.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Blood Compatible Polymers manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Blood Compatible Polymers by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Blood Compatible Polymers in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Polyethylene
- Polytetrafluoroethylene
- Polyetheretherketone
- Polyethersulfone
- Polyvinylchloride
- Polysulfone
- Poly Propalene
Applications
- Biomedical and Blood Contacting Devices
- Dental
- Drug delivery
Companies covered
- Sanofi S.A.
- Jiangsu Senolo Medical Technology
- Baxter International Inc
- TOPAS Advanced Polymers GmbH
- Evonik Industries AG
- Eastman Chemical Company
- DowDuPont
- Biomaterial USA LLC.
- ASM International
- AdvanSource Biomaterials Corporation
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Blood Compatible Polymers Market Size (2021-2032)
- 2.2.2 Global Blood Compatible Polymers Sales (2021-2032)
- 2.2.3 Global Blood Compatible Polymers Market Average Price (2021-2032)
- 2.3 Blood Compatible Polymers by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Polyethylene
- 2.3.3 Polytetrafluoroethylene
- 2.3.4 Polyetheretherketone
- 2.3.5 Polyethersulfone
- 2.3.6 Polyvinylchloride
- 2.3.7 Polysulfone
- 2.3.8 Poly Propalene
- 2.4 Blood Compatible Polymers by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Biomedical and Blood Contacting Devices
- 2.4.3 Dental
- 2.4.4 Drug delivery
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Blood Compatible Polymers Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Blood Compatible Polymers Sales (tons) of Manufacturers (2021-2026)
- 3.3 Global Blood Compatible Polymers Revenue of Manufacturers (2021-2026)
- 3.4 Global Blood Compatible Polymers Average Price by Manufacturers (2021-2026)
- 3.5 Global Blood Compatible Polymers Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Blood Compatible Polymers, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Blood Compatible Polymers, Product Type & Application
- 3.8 Global Manufacturers of Blood Compatible Polymers, Established Date
- 3.9 Global Blood Compatible Polymers Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Sanofi S.A.
- 4.1.1 Sanofi S.A. Company Information
- 4.1.2 Sanofi S.A. Business Overview
- 4.1.3 Sanofi S.A. Blood Compatible Polymers Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Sanofi S.A. Blood Compatible Polymers Product Portfolio
- 4.1.5 Sanofi S.A. Recent Developments
- 4.2 Jiangsu Senolo Medical Technology
- 4.2.1 Jiangsu Senolo Medical Technology Company Information
- 4.2.2 Jiangsu Senolo Medical Technology Business Overview
- 4.2.3 Jiangsu Senolo Medical Technology Blood Compatible Polymers Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Jiangsu Senolo Medical Technology Blood Compatible Polymers Product Portfolio
- 4.2.5 Jiangsu Senolo Medical Technology Recent Developments
- 4.3 Baxter International Inc
- 4.3.1 Baxter International Inc Company Information
- 4.3.2 Baxter International Inc Business Overview
- 4.3.3 Baxter International Inc Blood Compatible Polymers Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Baxter International Inc Blood Compatible Polymers Product Portfolio
- 4.3.5 Baxter International Inc Recent Developments
- 4.4 TOPAS Advanced Polymers GmbH
- 4.4.1 TOPAS Advanced Polymers GmbH Company Information
- 4.4.2 TOPAS Advanced Polymers GmbH Business Overview
- 4.4.3 TOPAS Advanced Polymers GmbH Blood Compatible Polymers Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 TOPAS Advanced Polymers GmbH Blood Compatible Polymers Product Portfolio
- 4.4.5 TOPAS Advanced Polymers GmbH Recent Developments
- 4.5 Evonik Industries AG
- 4.5.1 Evonik Industries AG Company Information
- 4.5.2 Evonik Industries AG Business Overview
- 4.5.3 Evonik Industries AG Blood Compatible Polymers Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Evonik Industries AG Blood Compatible Polymers Product Portfolio
- 4.5.5 Evonik Industries AG Recent Developments
- 4.6 Eastman Chemical Company
- 4.6.1 Eastman Chemical Company Company Information
- 4.6.2 Eastman Chemical Company Business Overview
- 4.6.3 Eastman Chemical Company Blood Compatible Polymers Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Eastman Chemical Company Blood Compatible Polymers Product Portfolio
- 4.6.5 Eastman Chemical Company Recent Developments
- 4.7 DowDuPont
- 4.7.1 DowDuPont Company Information
- 4.7.2 DowDuPont Business Overview
- 4.7.3 DowDuPont Blood Compatible Polymers Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 DowDuPont Blood Compatible Polymers Product Portfolio
- 4.7.5 DowDuPont Recent Developments
- 4.8 Biomaterial USA LLC.
- 4.8.1 Biomaterial USA LLC. Company Information
- 4.8.2 Biomaterial USA LLC. Business Overview
- 4.8.3 Biomaterial USA LLC. Blood Compatible Polymers Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Biomaterial USA LLC. Blood Compatible Polymers Product Portfolio
- 4.8.5 Biomaterial USA LLC. Recent Developments
- 4.9 ASM International
- 4.9.1 ASM International Company Information
- 4.9.2 ASM International Business Overview
- 4.9.3 ASM International Blood Compatible Polymers Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 ASM International Blood Compatible Polymers Product Portfolio
- 4.9.5 ASM International Recent Developments
- 4.10 AdvanSource Biomaterials Corporation
- 4.10.1 AdvanSource Biomaterials Corporation Company Information
- 4.10.2 AdvanSource Biomaterials Corporation Business Overview
- 4.10.3 AdvanSource Biomaterials Corporation Blood Compatible Polymers Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 AdvanSource Biomaterials Corporation Blood Compatible Polymers Product Portfolio
- 4.10.5 AdvanSource Biomaterials Corporation Recent Developments
5 Global Blood Compatible Polymers Market Scenario by Region
- 5.1 Global Blood Compatible Polymers Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Blood Compatible Polymers Sales by Region: 2021-2032
- 5.2.1 Global Blood Compatible Polymers Sales by Region: 2021-2026
- 5.2.2 Global Blood Compatible Polymers Sales by Region: 2027-2032
- 5.3 Global Blood Compatible Polymers Revenue by Region: 2021-2032
- 5.3.1 Global Blood Compatible Polymers Revenue by Region: 2021-2026
- 5.3.2 Global Blood Compatible Polymers Revenue by Region: 2027-2032
- 5.4 North America Blood Compatible Polymers Market Facts & Figures by Country
- 5.4.1 North America Blood Compatible Polymers Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Blood Compatible Polymers Sales by Country (2021-2032)
- 5.4.3 North America Blood Compatible Polymers Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Blood Compatible Polymers Market Facts & Figures by Country
- 5.5.1 Europe Blood Compatible Polymers Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Blood Compatible Polymers Sales by Country (2021-2032)
- 5.5.3 Europe Blood Compatible Polymers Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Blood Compatible Polymers Market Facts & Figures by Country
- 5.6.1 Asia Pacific Blood Compatible Polymers Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Blood Compatible Polymers Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Blood Compatible Polymers Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Blood Compatible Polymers Market Facts & Figures by Country
- 5.7.1 South America Blood Compatible Polymers Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Blood Compatible Polymers Sales by Country (2021-2032)
- 5.7.3 South America Blood Compatible Polymers Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Blood Compatible Polymers Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Blood Compatible Polymers Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Blood Compatible Polymers Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Blood Compatible Polymers Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Blood Compatible Polymers Sales by Type (2021-2032)
- 6.1.1 Global Blood Compatible Polymers Sales by Type (2021-2032) & (tons)
- 6.1.2 Global Blood Compatible Polymers Sales Market Share by Type (2021-2032)
- 6.2 Global Blood Compatible Polymers Revenue by Type (2021-2032)
- 6.2.1 Global Blood Compatible Polymers Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Blood Compatible Polymers Revenue Market Share by Type (2021-2032)
- 6.3 Global Blood Compatible Polymers Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Blood Compatible Polymers Sales by Application (2021-2032)
- 7.1.1 Global Blood Compatible Polymers Sales by Application (2021-2032) & (tons)
- 7.1.2 Global Blood Compatible Polymers Sales Market Share by Application (2021-2032)
- 7.2 Global Blood Compatible Polymers Revenue by Application (2021-2032)
- 7.2.1 Global Blood Compatible Polymers Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Blood Compatible Polymers Revenue Market Share by Application (2021-2032)
- 7.3 Global Blood Compatible Polymers Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Blood Compatible Polymers Value Chain Analysis
- 8.1.1 Blood Compatible Polymers Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Blood Compatible Polymers Production Mode & Process
- 8.2 Blood Compatible Polymers Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Blood Compatible Polymers Distributors
- 8.2.3 Blood Compatible Polymers Customers
9 Global Blood Compatible Polymers Analyzing Market Dynamics
- 9.1 Blood Compatible Polymers Industry Trends
- 9.2 Blood Compatible Polymers Industry Drivers
- 9.3 Blood Compatible Polymers Industry Opportunities and Challenges
- 9.4 Blood Compatible Polymers Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst